Medifocus (MDFZF) Stock Price, News & Analysis

Company Overview

Medifocus, Inc. is a clinical-stage medical device and biotechnology company focused on developing minimally invasive therapies for common conditions affecting the cardiovascular and urological systems. Headquartered in Carlsbad, California, the company is advancing proprietary MicroSeal™ technology designed to treat small‐to‐medium abdominal aortic aneurysms (AAA) and benign prostatic hyperplasia (BPH). Medifocus’s platform approach utilizes a percutaneous catheter delivery system to deploy a biocompatible sealant, aiming to reduce procedural risks and improve patient outcomes compared with traditional open surgery or permanent implants.

The company’s lead product candidate, MicroSeal AAA, is in the investigational stage for use in patients with small aneurysms who are not candidates for conventional endovascular stent grafts. In parallel, Medifocus is developing a MicroSeal application for BPH, targeting men with moderately enlarged prostates who seek an alternative to medication or invasive surgical procedures. Medifocus conducts clinical trials under U.S. Food and Drug Administration (FDA) guidelines and pursues regulatory clearances internationally, with a focus on building strategic partnerships to accelerate market entry and expand its global footprint.

Founded in 2004, Medifocus has leveraged over a decade of research and development to refine its proprietary sealant formulation and delivery catheters. With operations in North America and collaborating sites across Europe, the company maintains relationships with leading contract research organizations and manufacturing partners. Medifocus is led by an executive team with extensive experience in medical device innovation, clinical development, and commercialization, supported by a board of directors comprising seasoned life-science entrepreneurs and clinicians. The company continues to advance its pipeline through clinical milestones and aims to bring safer, cost-effective alternatives to patients worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 74,462 shs
• Market Capitalization: $18 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MDFZF Stock Analysis - Frequently Asked Questions

How do I buy shares of Medifocus?

Shares of MDFZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MDFZF
• CIK: 1603961
• Web: www.medifocusinc.com
• Phone: (410) 290-5734
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 184,980,000
• Free Float: N/A
• Market Cap: $18 thousand
• Optionable: Not Optionable
• Beta: N/A